Thomas E. Valentyn - 12 Feb 2024 Form 4 Insider Report for REGAL REXNORD CORP (RRX)

Signature
/s/ Thomas E. Valentyn
Issuer symbol
RRX
Transactions as of
12 Feb 2024
Transactions value $
-$1,845,051
Form type
4
Filing time
14 Feb 2024, 18:56:18 UTC
Previous filing
17 Jan 2024
Next filing
26 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RRX Common Stock Options Exercise $514K +9.38K +46.06% $54.79 29.7K 12 Feb 2024 Direct
transaction RRX Common Stock Tax liability -$811K -5.26K -17.67% $154.32 24.5K 12 Feb 2024 Direct
transaction RRX Common Stock Options Exercise $589K +7.65K +31.24% $76.99 32.1K 12 Feb 2024 Direct
transaction RRX Common Stock Tax liability -$858K -5.56K -17.29% $154.32 26.6K 12 Feb 2024 Direct
transaction RRX Common Stock Options Exercise $685K +9.25K +34.79% $74.04 35.8K 12 Feb 2024 Direct
transaction RRX Common Stock Tax liability -$1.03M -6.69K -18.67% $154.32 29.1K 12 Feb 2024 Direct
transaction RRX Common Stock Options Exercise $641K +8.22K +28.2% $78.05 37.4K 12 Feb 2024 Direct
transaction RRX Common Stock Tax liability -$935K -6.06K -16.21% $154.32 31.3K 12 Feb 2024 Direct
transaction RRX Common Stock Sale -$576K -3.72K -11.9% $154.67 27.6K 12 Feb 2024 Direct F1
transaction RRX Common Stock Sale -$62K -400 -1.45% $154.96 27.2K 12 Feb 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RRX Stock Appreciation Rights Options Exercise $0 -9.38K -100% $0.00* 0 12 Feb 2024 Common Stock 9.38K $54.79 Direct F3
transaction RRX Stock Appreciation Rights Options Exercise $0 -7.65K -100% $0.00* 0 12 Feb 2024 Common Stock 7.65K $76.99 Direct F3
transaction RRX Stock Appreciation Rights Options Exercise $0 -9.25K -100% $0.00* 0 12 Feb 2024 Common Stock 9.25K $74.04 Direct F4
transaction RRX Stock Appreciation Rights Options Exercise $0 -8.22K -80% $0.00 2.05K 12 Feb 2024 Common Stock 8.22K $78.05 Direct F4
holding RRX Stock Appreciation Rights 7.4K 12 Feb 2024 Common Stock 7.4K $84.39 Direct F5
holding RRX Stock Appreciation Rights 5.78K 12 Feb 2024 Common Stock 5.78K $133.77 Direct F5
holding RRX Stock Appreciation Rights 4.44K 12 Feb 2024 Common Stock 4.44K $151.27 Direct F5
holding RRX Stock Appreciation Rights 5.02K 12 Feb 2024 Common Stock 5.02K $154.20 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in Column 4 is a weighted average price. The prices actually received ranged from $153.95 to $154.95. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
F2 The price in Column 4 is a weighted average price. The prices actually received ranged from $154.96 to $154.97. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
F3 Granted as stock-settled Stock Appreciation Rights ("SARs") under the 2013 Equity Incentive Plan. The SARs vest and become exercisable 40% on the second anniversary, 60% on the third anniversary, 80% on the fourth anniversary and 100% on the fifth anniversary of the date of the grant.
F4 Granted as stock-settled SARs under the 2018 Equity Incentive Plan. The SARs vest and become exercisable 40% on the second anniversary, 60% on the third anniversary, 80% on the fourth anniversary and 100% on the fifth anniversary of the date of the grant.
F5 Granted as stock-settled SARs under the 2018 Equity Incentive Plan. The SARs vest and become exercisable 34% on the first anniversary, 67% on the second anniversary and 100% on the third anniversary of the date of the grant.

Remarks:

*Executive Vice President, General Counsel and Secretary